ClinicalTrials.govpublic full text
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
head and neck cancer, squamous cell cancer, imatinib mesylate, gleevec, imatinib, sti571, docetaxel, taxotere, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906288
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.